SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Momenta Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: DewDiligence_on_SI who wrote (2776)3/7/2011 10:20:27 AM
From: semi_infinite   Respond to of 3027
 
I am not a lawyer. There are a number of items scheduled prior to the start of discovery. Are those pre-discovery action items not important. Why do you believe that the November 2012 date the most significant?



To: DewDiligence_on_SI who wrote (2776)3/7/2011 3:22:59 PM
From: Biomaven  Read Replies (1) | Respond to of 3027
 
Quite honestly, I can draw no reasonable inference from this discovery date to anything at all regarding chances of approval.

I view the chance of an injunction preventing a Teva launch as minuscule (which was my same reaction to the chance of Sanofi succeeding in preventing MNTA's launch). So from Teva's perspective, why not string things out as long as possible?

Peter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News